跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
APO-TERAZOSIN TABLET 2 mg - HSA Drug Approval Details
Approvals
/
HSA
/
APO-TERAZOSIN TABLET 2 mg
Approved
THERAPEUTIC
APO-TERAZOSIN TABLET 2 mg
APOTEX INC (SIGNET DRIVE)
🇸🇬 Health Sciences Authority
Approval Date
Sep 21, 2005
Approval ID
ac010b5bb9cd7af6
Company
APOTEX INC (SIGNET DRIVE)
Type
Therapeutic
Approval Details
Approval Id
ac010b5bb9cd7af6
Drug Name
APO-TERAZOSIN TABLET 2 mg
Product Name
APO-TERAZOSIN TABLET 2 mg
Approval Number
SIN12672P
Approval Date
2005-09-21
Registrant
PHARMAFORTE SINGAPORE PTE LTD
Licence Holder
PHARMAFORTE SINGAPORE PTE LTD
Drug Type
Therapeutic
Forensic Classification
Prescription Only
Dosage Form
TABLET
Route Of Administration
ORAL
Pharma Manufacturer Name
PHARMAFORTE SINGAPORE PTE LTD
Company Detail Path
/organization/pharmaforte-singapore-pte-ltd
Active Ingredients
TERAZOSIN HCl
2 mg
TERAZOSIN HCl
2 mg
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
Sep 21, 2005
Approval ID
ac010b5bb9cd7af6
Type
Therapeutic
Back to HSA Approvals